Mirzotamab,95.0%
产品编号:Bellancom-P99740| CAS NO:2229859-11-2
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,
Mirzotamab
| 产品介绍 | Mirzotamab 是一种靶向 CD276/B7-H3 的 IgG1κ 抗体。Mirzotamab 可以与 BCL2L1 抑制剂 Clezutoclaxum (HY-137774) 结合形成 Mirzotamab clezutoclax (HY-P99741),可参与紫杉烷研究复发/难治性实体瘤的研究。Mirzotamab clezutoclax (ABBV-155) 是一种靶向抗体偶联物 (ADC)。 |
|---|---|
| 生物活性 | Mirzotamab is an IgG1κ antibody targeting to CD276/B7-H3. Mirzotamab can conjugates with Clezutoclaxum (HY-137774), an BCL2L1 inhibitor to form Mirzotamab clezutoclax (HY-P99741), involving in research with taxane research in relapsed/refractory solid tumors. Mirzotamab clezutoclax (ABBV-155) is a targeted antibody drug conjugate (ADC). |
| 体外研究 | |
| 体内研究 | |
| 体内研究 | |
| 性状 | Liquid |
| 溶解性数据 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 |
Please store the product under the recommended conditions in the Certificate of Analysis. |
| 参考文献 |

浙公网安备 33010802013016号